Promoter polymorphism of rgs2 gene is associated with change of blood pressure in subjects with antihypertensive treatment: The azelnidipine and temocapril in hypertensive patients with type 2 diabetes study

International Journal of Hypertension

Volumn 2010, Issue , 2010, Pages

  Sugimoto, Ken ^a   Katsuya, Tomohiro ^a   Kamide, Kei ^a   Fujisawa, Tomomi ^a   Shimaoka, Izumi ^a   Ohishi, Mitsuru ^a   Morishita, Ryuichi ^a   Ogihara, Toshio ^b   Rakugi, Hiromi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALPHA ADDUCIN; ANGIOTENSINOGEN; AZELNIDIPINE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BRADYKININ B2 RECEPTOR; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; FAS LIGAND; G PROTEIN COUPLED RECEPTOR KINASE 4; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); RGS2 PROTEIN; SODIUM CHLORIDE COTRANSPORTER; TEMOCAPRIL; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL;

ACE GENE; ADD1 GENE; ADIPOQ GENE; ADRB1 GENE; ADRB2 GENE; ADRB3 GENE; ADULT; AGE; AGED; AGT GENE; AGTR1 GENE; ALDH2 GENE; ARHGAP8 GENE; ARTICLE; BDKRB2 GENE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DNA EXTRACTION; DRUG DNA INTERACTION; DRUG DOSE INCREASE; FASL GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; GRK4 GENE; HOGG1 GENE; HUMAN; HYPERTENSION; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAL TIME POLYMERASE CHAIN REACTION; RGS2 GENE; RNA EXTRACTION; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SLC12A3 GENE; SYSTOLIC BLOOD PRESSURE; TAQMAN POLYMERASE CHAIN REACTION; TGFB GENE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79960668514     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2010/196307     Document Type: Article

References (27)

1. Kohara K., Tabara Y., Nakura J., Imai Y., Ohkubo T., Hata A., Soma M., Nakayama T., Umemura S., Hirawa N., Ueshima H., Kita Y., Ogihara T., Katsuya T., Takahashi N., Tokunaga K., Miki T., Identification of hypertension- susceptibility genes and pathways by a systemic multiple candidate gene approach: the millennium genome project for hypertension. Hypertension Research 2008 31 2 203 212 2-s2.0-41549085053 10.1291/hypres.31.203 (Pubitemid 351461098)
2. Watanabe Y., Metoki H., Ohkubo T., tohkubo@mail.tains.tohoku.ac.jp Katsuya T., Tabara Y., Kikuya M., Hirose T., Sugimoto K., Asayama K., Inoue R., Hara A., Obara T., Nakura J., Kohara K., Totsune K., Ogihara T., Rakugi H., Miki T., Imai Y., Accumulation of common polymorphisms is associated with development of hypertension: a 12-year follow-up from the Ohasama study. Hypertension Research 2010 33 2 129 134 2-s2.0-0034595316 10.1038/hr.2009.193
3. Chapman A. B., Schwartz G. L., Boerwinkle E., Turner S. T., Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney International 2002 61 3 1047 1055 2-s2.0-0036190169 10.1046/j.1523-1755.2002.00200.x (Pubitemid 34175474)
4. Benetos A., Cambien F., Gautier S., Ricard S., Safar M., Laurent S., Lacolley P., Poirier O., Topouchian J., Asmar R., Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 1996 28 6 1081 1084 2-s2.0-10544228945 (Pubitemid 26415828)
5. Higaki J., Baba S., Katsuya T., Sato N., Ishikawa K., Mannami T., Ogata J., Ogihara T., Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita study. Circulation 2000 101 17 2060 2065 2-s2.0-0034595316 (Pubitemid 30233169)
6. Asai T., Ohkubo T., Katsuya T., Higaki J., Fu Y., Fukuda M., Hozawa A., Matsubara M., Kitaoka H., Tsuji I., Araki T., Satoh H., Hisamichi S., Imai Y., Ogihara T., Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama study. Hypertension 2001 38 6 1321 1324 2-s2.0-0035679238 (Pubitemid 34033410)
7. Ishikawa K., Baba S., Katsuya T., Iwai N., Asai T., Fukuda M., Takiuchi S., Fu Y., Mannami T., Ogata J., Higaki J., Ogihara T., T+31C polymorphism of angiotensinogen gene and essential hypertension. Hypertension 2001 37 2 281 285 2-s2.0-0035095243 (Pubitemid 32201172)
8. Katsuya T., Iwashima Y., Sugimoto K., Motone M., Asai T., Fukuda M., Fu Y., Hatanaka Y., Ohishi M., Rakugi H., Higaki J., Ogihara T., Effects of antihypertensive drugs and gene variants in the renin-angiotensin system. Hypertension Research 2001 24 4 463 467 2-s2.0-0034860163 10.1291/hypres.24.463 (Pubitemid 32791824)
9. Sugimoto K., Hozawa A., Katsuya T., Matsubara M., Ohkubo T., Tsuji I., Motone M., Higaki J., Hisamachi S., Imai Y., Ogihara T., Alpha-adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study. Journal of Hypertension 2002 20 9 1779 1784 2-s2.0-18544382859 10.1097/00004872-200209000-00022
10. Fu Y., Katsuya T., Matsuo A., Yamamoto K., Akasaka H., Takami Y., Iwashima Y., Sugimoto K., Ishikawa K., Ohishi M., Rakugi H., Ogihara T., Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy. Hypertension Research 2004 27 12 933 938 2-s2.0-20144365634 10.1291/hypres.27.933 (Pubitemid 40425395)
11. Matsuo A., Katsuya T., Ishikawa K., Sugimoto K., Iwashima Y., Yamamoto K., Ohishi M., Rakugi H., Ogihara T., G2736A polymorphism of thiazide-sensitive Na-Cl cotransporter gene predisposes to hypertension in young women. Journal of Hypertension 2004 22 11 2123 2127 2-s2.0-7744220000 10.1097/00004872-200411000- 00014 (Pubitemid 39463805)
12. Ohashi K., Ouchi N., Kihara S., Funahashi T., Nakamura T., Sumitsuji S., Kawamoto T., Matsumoto S., Nagaretani H., Kumada M., Okamoto Y., Nishizawa H., Kishida K., Maeda N., Hiraoka H., Iwashima Y., Ishikawa K., Ohishi M., Katsuya T., Rakugi H., Ogihara T., Matsuzawa Y., Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. Journal of the American College of Cardiology 2004 43 7 1195 1200 2-s2.0-11144356189 10.1016/j.jacc.2003.10.049 (Pubitemid 38452596)
13. Sugimoto K., Katsuya T., Ohkubo T., Hozawa A., Yamamoto K., Matsuo A., Rakugi H., Tsuji I., Imai Y., Ogihara T., Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama study. Hypertension Research 2004 27 8 551 556 2-s2.0-5044223949 10.1291/hypres.27.551 (Pubitemid 39335072)
14. Masuo K., kmasuo@baker.edu.au Katsuya T., Fu Y., Rakugi H., Ogihara T., Tuck M. L., β 2- and β 3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005 111 25 3429 3434 2-s2.0-10244267463 10.1161/CIRCULATIONAHA.104. 519652 (Pubitemid 40923396)
15. Hanasaki H., Takemura Y., takemura@geriat.med.osaka-u.ac.jp Fukuo K., Ohishi M., Onishi M., Yasuda O., Katsuya T., Awata N., Kato N., Ogihara T., Rakugi H., Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction. Hypertension Research 2009 32 4 261 264 2-s2.0-1642460605 10.1038/hr.2009.2
16. Katayama S., Kawamori R., Iwamoto Y., Saito I., Kuramoto K., In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of 130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study. Hypertension Research 2008 31 8 1499 1508 2-s2.0-55449086285
17. Lynch A. I., Boerwinkle E., Davis B. R., Ford C. E., Eckfeldt J. H., Leiendecker-Foster C., Arnett D. K., Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. Journal of the American Medical Association 2008 299 3 296 307 2-s2.0-38349158422 10.1001/jama.299.3.296 (Pubitemid 351159366)
18. Beitelshees A. L., Gong Y., Wang D., Schork N. J., Cooper-DeHoff R. M., Langaee T. Y., Shriver M. D., Sadee W., Knot H. J., Pepine C. J., Johnson J. A., KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST). Pharmacogenetics and Genomics 2007 17 9 719 729 2-s2.0-34547919927 10.1097/FPC.0b013e32810f2e3c (Pubitemid 47263067)
19. Takahashi N., Smithies O., Gene targeting approaches to analyzing hypertension. Journal of the American Society of Nephrology 1999 10 7 1598 1605 2-s2.0-0033022137 (Pubitemid 29297537)
20. Lifton R. P., Gharavi A. G., Geller D. S., Molecular mechanisms of human hypertension. Cell 2001 104 4 545 556 2-s2.0-0035936780 10.1016/S0092-8674(01) 00241-0 (Pubitemid 32201949)
21. De Vries L., Zheng B., Fischer T., Elenko E., Farquhar M. G., The regulator of G protein signaling family. Annual Review of Pharmacology and Toxicology 2000 40 235 271 2-s2.0-0034128414 10.1146/annurev.pharmtox.40.1.235 (Pubitemid 30340681)
22. Sinnarajah S., Dessauer C. W., Srikumar D., Chen J., Yuen J., Yilma S., Dennis J. C., Morrison E. E., Vodyanoy V., Kehrl J. H., RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature 2001 409 6823 1051 1055 2-s2.0-0035931884 10.1038/35059104 (Pubitemid 32204058)
23. Ingi T., Krumins A. M., Chidiac P., Brothers G. M., Chung S., Snow B. E., Barnes C. A., Lanahan A. A., Siderovski D. P., Ross E. M., Gilman A. G., Worley P. F., Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. Journal of Neuroscience 1998 18 18 7178 7188 2-s2.0-17344374133 (Pubitemid 28425805)
24. Heximer S. P., Knutsen R. H., Sun X., Kaltenbronn K. M., Rhee M.-H., Peng N., Oliveira-dos-Santos A., Penninger J. M., Muslin A. J., Steinberg T. H., Wyss J. M., Mecham R. P., Blumer K. J., Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. Journal of Clinical Investigation 2003 111 4 445 452 2-s2.0-0037330249 10.1172/JCI200315598 (Pubitemid 36228001)
25. Tang M., Wang G., Lu P., Karas R. H., Aronovitz M., Heximer S. P., Kaltenbronn K. M., Blumer K. J., Siderovski D. P., Zhu Y., Mendelsohn M. E., Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nature Medicine 2003 9 12 1506 1512 2-s2.0-10744233990 10.1038/nm958 (Pubitemid 38004778)
26. Yang J., Kamide K., Kokubo Y., Takiuchi S., Tanaka C., Banno M., Miwa Y., Yoshii M., Horio T., Okayama A., Tomoike H., Kawano Y., Miyata T., Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. Journal of Hypertension 2005 23 8 1497 1505 2-s2.0-23344435021 (Pubitemid 41104821)
27. Riddle E. L., Rana B. K., Murthy K. K., Rao F., Eskin E., O'Connor D. T., Insel P. A., Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. Hypertension 2006 47 3 415 420 2-s2.0-33644972273 10.1161/01.HYP.0000200714.81990.61 (Pubitemid 43740284)